| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 2,6000% | ₹2050% | 1,300 | ₹0.05-50% | 48,7500% |
| - | - | 1,320 | ₹0.150% | 6,5000% |
| - | - | 1,340 | ₹0.050% | 56,5500% |
| 6500% | ₹135.650% | 1,360 | ₹0.05-83.33% | 26,000-18.36% |
| 00% | ₹101.50% | 1,380 | ₹0.05-50% | 28,600-8.33% |
| 17,5503.84% | ₹104.45-0.52% | 1,400 | ₹0.10% | 81,250-20.38% |
| 4,5500% | ₹66.10% | 1,420 | ₹0.05-80% | 80,600-6.06% |
| 11,7000% | ₹62.5-4.79% | 1,440 | ₹0.05-80% | 1,63,800-25.66% |
| 17,550-3.57% | ₹41.75-5.11% | 1,460 | ₹0.05-87.5% | 1,44,300-32.31% |
| 1,10,500-8.60% | ₹3029.87% | 1,480 | ₹0.1-80% | 3,02,250-32.51% |
| 6,31,150-21.31% | ₹0.05-98.96% | 1,500 | ₹0.05-97.87% | 2,43,750-40.85% |
| 4,70,600-26.42% | ₹0.05-95.45% | 1,520 | ₹23.8533.24% | 66,950-33.54% |
| 6,76,650-10.64% | ₹0.05-83.33% | 1,540 | ₹36.3-2.94% | 26,650-4.65% |
| 2,82,750-22.45% | ₹0.05-83.33% | 1,560 | ₹58.655.67% | 39,650-11.59% |
| 1,83,300-20.33% | ₹0.1-50% | 1,580 | ₹73.55-12.44% | 7,800-25% |
| 2,39,850-21.82% | ₹0.05-66.66% | 1,600 | ₹96-8.48% | 20,800-3.03% |
| 60,450-34.96% | ₹0.05-66.66% | 1,620 | ₹114.85-4.68% | 2,6000% |
| 35,100-25% | ₹0.05-75% | 1,640 | ₹158.450% | 4,5500% |
| 50,700-26.41% | ₹0.05-50% | 1,660 | ₹156.70% | 6500% |
| 24,700-36.66% | ₹0.05-50% | 1,680 | - | - |
| 74,100-5.78% | ₹0.05-50% | 1,700 | ₹210.5-0.23% | 2,6000% |
| 1,78,7500% | ₹0.050% | 1,720 | - | - |
| 3,900-68.42% | ₹0.050% | 1,760 | - | - |
| 74,1000% | ₹0.10% | 1,800 | ₹2980% | 1,3000% |
Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.
The VAI designation now clears the way for significant specialised launches, such as the Abraxane generic.
The company is now able to pursue important speciality medicine launches because to its VAI classification.
Here are some of the stocks that may see significant price movement today: Larsen & Toubro, Tata Power, Biocon, etc.
Cipla's total research and development expenditure for the quarter reached ₹385 Crore, representing 5.5% of total sales and reflecting a 2% increase year-on-year.
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
Here are some of the stocks that may see significant price movement today: Vedanta, Uno Minda, Reliance Power, etc.
On February 6, 2023, Cipla informed exchanges that I-T department officials had searched some of company offices and manufacturing units.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
